Table 1.
Target | Reinforcer | p-value | Microinjection | p-value | Reinf.*Micro. | p-value |
---|---|---|---|---|---|---|
| ||||||
Eotaxin | F(1,13) = 12.29 | p = 0.0034 | F(1,13) = 1.27 | ns | F(1,13) = 10.01 | p = 0.008 |
CX3CL1 | F(1,13) = 47.22 | p < 0.0001 | F(1,13) = 0.0002 | ns | F(1,13) = 0.013 | ns |
GM-CSF | F(1,13) = 1.730 | ns | F(1,13) = 6.71 | p = 0.0224 | F(1,13) = 3.663 | ns |
IFNγ | F(1,13) = 16.62 | p = 0.0013 | F(1,13) = 0.873 | ns | F(1,13) = 9.079 | p = 0.01 |
IL-4 | F(1,13) = 42.42 | p < 0.0001 | F(1,13) = 0.003 | ns | F(1,13) = 0.011 | ns |
IL-5 | F(1,13) = 34.94 | p < 0.0001 | F(1,13) = 3.636 | ns | F(1,13) = 0.907 | ns |
IL-18 | F(1,13) = 75.45 | p < 0.0001 | F(1,13) = 4.386 | ns | F(1,13) = 0.727 | ns |
CXCL2 | F(1,13) = 19.91 | p = 0.0006 | F(1,13) = 5.885 | p = 0.0306 | F(1,13) = 6.544 | p = 0.024 |
CCL5 | F(1,13) = 30.22 | p = 0.0001 | F(1,13) = 19.84 | p = 0.0006 | F(1,13) = 0.089 | ns |
VEGF | F(1,13) = 6.43 | p = 0.0248 | F(1,13) = 4.57 | ns | F(1,13) = 15.35 | p = 0.002 |